Cargando…
Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050772/ https://www.ncbi.nlm.nih.gov/pubmed/35303118 http://dx.doi.org/10.1007/s00134-022-06668-3 |
| _version_ | 1784696442416267264 |
|---|---|
| author | Hagel, Stefan Bach, Friedhelm Brenner, Thorsten Bracht, Hendrik Brinkmann, Alexander Annecke, Thorsten Hohn, Andreas Weigand, Markus Alexander Michels, Guido Kluge, Stefan Nierhaus, Axel Jarczak, Dominik König, Christina Weismann, Dirk Frey, Otto Witzke, Dominic Müller, Carsten Bauer, Michael Kiehntopf, Michael Neugebauer, Sophie Lehmann, Thomas Roberts, Jason A. Pletz, Mathias W. |
| author_facet | Hagel, Stefan Bach, Friedhelm Brenner, Thorsten Bracht, Hendrik Brinkmann, Alexander Annecke, Thorsten Hohn, Andreas Weigand, Markus Alexander Michels, Guido Kluge, Stefan Nierhaus, Axel Jarczak, Dominik König, Christina Weismann, Dirk Frey, Otto Witzke, Dominic Müller, Carsten Bauer, Michael Kiehntopf, Michael Neugebauer, Sophie Lehmann, Thomas Roberts, Jason A. Pletz, Mathias W. |
| author_sort | Hagel, Stefan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9050772 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90507722022-05-07 Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial Hagel, Stefan Bach, Friedhelm Brenner, Thorsten Bracht, Hendrik Brinkmann, Alexander Annecke, Thorsten Hohn, Andreas Weigand, Markus Alexander Michels, Guido Kluge, Stefan Nierhaus, Axel Jarczak, Dominik König, Christina Weismann, Dirk Frey, Otto Witzke, Dominic Müller, Carsten Bauer, Michael Kiehntopf, Michael Neugebauer, Sophie Lehmann, Thomas Roberts, Jason A. Pletz, Mathias W. Intensive Care Med Correction Springer Berlin Heidelberg 2022-03-18 2022 /pmc/articles/PMC9050772/ /pubmed/35303118 http://dx.doi.org/10.1007/s00134-022-06668-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Hagel, Stefan Bach, Friedhelm Brenner, Thorsten Bracht, Hendrik Brinkmann, Alexander Annecke, Thorsten Hohn, Andreas Weigand, Markus Alexander Michels, Guido Kluge, Stefan Nierhaus, Axel Jarczak, Dominik König, Christina Weismann, Dirk Frey, Otto Witzke, Dominic Müller, Carsten Bauer, Michael Kiehntopf, Michael Neugebauer, Sophie Lehmann, Thomas Roberts, Jason A. Pletz, Mathias W. Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial |
| title | Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial |
| title_full | Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial |
| title_fullStr | Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial |
| title_full_unstemmed | Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial |
| title_short | Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial |
| title_sort | correction to: effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050772/ https://www.ncbi.nlm.nih.gov/pubmed/35303118 http://dx.doi.org/10.1007/s00134-022-06668-3 |
| work_keys_str_mv | AT hagelstefan correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT bachfriedhelm correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT brennerthorsten correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT brachthendrik correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT brinkmannalexander correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT anneckethorsten correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT hohnandreas correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT weigandmarkusalexander correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT michelsguido correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT klugestefan correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT nierhausaxel correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT jarczakdominik correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT konigchristina correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT weismanndirk correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT freyotto correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT witzkedominic correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT mullercarsten correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT bauermichael correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT kiehntopfmichael correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT neugebauersophie correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT lehmannthomas correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT robertsjasona correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT pletzmathiasw correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial AT correctiontoeffectoftherapeuticdrugmonitoringbaseddoseoptimizationofpiperacillintazobactamonsepsisrelatedorgandysfunctioninpatientswithsepsisarandomizedcontrolledtrial |